Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 9.11.2020 | EN | Official Journal of the European Union | C 378/30 |

---

Judgment of the General Court of 9 September 2020 — Glaxo Group Ltd v EUIPO (Shade of the colour purple)

(Case T-187/19) [(1)](#ntr1-C_2020378EN.01003002-E0001)

(EU trade mark - Application for an EU trade mark consisting of a shade of the colour purple - Absolute ground for refusal - Lack of distinctive character - Article 7(1)(b) of Regulation (EU) 2017/1001 - Lack of distinctive character acquired through use - Article 7(3) of Regulation 2017/1001)

(2020/C 378/36)

Language of the case: English

Parties

Applicant: Glaxo Group Ltd (Brentford, United Kingdom) (represented by: S. Malynicz, QC, S. Baran, Barrister, and R. Jacob, Solicitor)

Defendant: European Union Intellectual Property Office (represented by: S. Hanne and H. O’Neill, acting as Agents)

Re:

Action brought against the decision of the First Board of Appeal of EUIPO of 15 January 2019 (Case R 1870/2017-1), concerning an application for registration of a sign consisting of a shade of the colour purple as an EU trade mark:

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Glaxo Group Ltd to pay the costs. |

---

---

[Top](#document1)